ELX-02

ELX-02 · Eloxx Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ELX-02, covering 2021-03-16 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ELX-02 in Patients With Alport Syndrome [Phase 2]